Iterum Therapeutics Plc (ITRMF)
0.042
-0.01
(-15.83%)
USD |
OTCM |
Apr 02, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.876M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -96.56% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 3.944 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -4.570 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.92% |
Profile
| Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland. |
| URL | http://www.iterumtx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Dublin |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 02, 2026 (est.) |
| Last Earnings Release | Apr. 02, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland. |
| URL | http://www.iterumtx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Dublin |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 02, 2026 (est.) |
| Last Earnings Release | Apr. 02, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |